Family Medicine · Springfield, MO
NPI
1245363993
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3525 S. National Ave, #101
Springfield, MO, 65807
Phone (417) 269-9950
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,509
38 services
Medicare patients, 2023
33
Average age 64
Drug cost, 2024
$4.5M
4,910 prescriptions
Company payments, 2025
$60K
From 17 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Stephen R Adams was code 99214 (office e&m - established), 33 times for 30 patients. In total Stephen R Adams billed 38 services in 4 codes, and Medicare paid $1,509.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 33 | 30 | $41.53 | $1,370 |
By year: 2022 $6,216 for 117 services; 2023 $1,509 for 38 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen R Adams prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 376 prescriptions and refills. In total Stephen R Adams wrote 4,910 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 376 | 376 | 51 | $1.5M |
| Rosuvastatin Calcium Generic | 252 | 368 | 44 | $1,167 |
| Dovato Dolutegravir Sodium/Lamivudine | 222 | 228 | 32 | $689K |
| Atorvastatin Calcium Generic | 215 | 278 | 31 | $756 |
| Tivicay Dolutegravir Sodium | 161 | 161 | 20 | $427K |
| Montelukast Sodium Generic | 140 | 185 | 21 | $439 |
| Losartan Potassium Generic | 116 | 149 | 24 | $576 |
| Valacyclovir Valacyclovir Hcl | 97 | 109 | 12 | $4,314 |
| Fluticasone Propionate Generic | 96 | 111 | 13 | $744 |
| Mirtazapine Generic | 94 | 94 | 14 | $1,526 |
| Tamsulosin Hcl Generic | 86 | 97 | Under 11 | $458 |
| Amlodipine Besylate Generic | 83 | 123 | 16 | $238 |
| Omeprazole Generic | 79 | 94 | 14 | $353 |
| Metoprolol Succinate Generic | 75 | 81 | 12 | $184 |
| Descovy Emtricitabine/Tenofov Alafenam | 74 | 74 | 12 | $158K |
Brand drugs: 1,508 claims; generic drugs: 3,389 claims; opioid claims: 107.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen R Adams $60K ($60K in general payments such as food, travel and fees) from 17 companies. The largest payer was ViiV Healthcare Company with $47K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 85 | $47K |
| Gilead Sciences, Inc. GILD | 51 | $12K |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $210 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $138 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $135 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Merck Sharp & Dohme LLC MRK | 5 | $112 |
| EMD Serono, Inc. MRK.DE | 5 | $94.76 |
| Lundbeck LLC | 5 | $85.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.